Literature DB >> 31696233

Cerebellar contribution to the cognitive alterations in SCA1: evidence from mouse models.

Melissa Asher1, Juao-Guilherme Rosa1, Orion Rainwater2, Lisa Duvick2, Michael Bennyworth3, Ruo-Yah Lai4, Sheng-Han Kuo4, Marija Cvetanovic1,3.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by abnormal expansion of glutamine (Q) encoding CAG repeats in the gene Ataxin-1 (ATXN1). Although motor and balance deficits are the core symptoms of SCA1, cognitive decline is also commonly observed in patients. While mutant ATXN1 is expressed throughout the brain, pathological findings reveal severe atrophy of cerebellar cortex in SCA1 patients. The cerebellum has recently been implicated in diverse cognitive functions, yet to what extent cerebellar neurodegeneration contributes to cognitive alterations in SCA1 remains poorly understood. Much of our understanding of the mechanisms underlying pathogenesis of motor symptoms in SCA1 comes from mouse models. Reasoning that mouse models could similarly offer important insights into the mechanisms of cognitive alterations in SCA1, we tested cognition in several mouse lines using Barnes maze and fear conditioning. We confirmed cognitive deficits in Atxn1154Q/2Q knock-in mice with brain-wide expression of mutant ATXN1 and in ATXN1 null mice. We found that shorter polyQ length and haploinsufficiency of ATXN1 do not cause significant cognitive deficits. Finally, ATXN1[82Q ] transgenic mice-with cerebellum limited expression of mutant ATXN1-demonstrated milder impairment in most aspects of cognition compared to Atxn1154Q/2Q mice, supporting the concept that cognitive deficits in SCA1 arise from a combination of cerebellar and extra-cerebellar dysfunctions.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31696233      PMCID: PMC8216071          DOI: 10.1093/hmg/ddz265

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  95 in total

Review 1.  Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.

Authors:  Udo Rüb; Ludger Schöls; Henry Paulson; Georg Auburger; Pawel Kermer; Joanna C Jen; Kay Seidel; Horst-Werner Korf; Thomas Deller
Journal:  Prog Neurobiol       Date:  2013-02-21       Impact factor: 11.685

2.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia.

Authors:  Vikram G Shakkottai; Amit Batla; Kailash Bhatia; William T Dauer; Christian Dresel; Martin Niethammer; David Eidelberg; Robert S Raike; Yoland Smith; H A Jinnah; Ellen J Hess; Sabine Meunier; Mark Hallett; Rachel Fremont; Kamran Khodakhah; Mark S LeDoux; Traian Popa; Cécile Gallea; Stéphane Lehericy; Andreea C Bostan; Peter L Strick
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 3.  Reappraising the cerebellum: what does the hindbrain contribute to the forebrain?

Authors:  H C Leiner; A L Leiner; R S Dow
Journal:  Behav Neurosci       Date:  1989-10       Impact factor: 1.912

4.  Altered cerebellar connectivity in autism and cerebellar-mediated rescue of autism-related behaviors in mice.

Authors:  Catherine J Stoodley; Anila M D'Mello; Jacob Ellegood; Vikram Jakkamsetti; Pei Liu; Mary Beth Nebel; Jennifer M Gibson; Elyza Kelly; Fantao Meng; Christopher A Cano; Juan M Pascual; Stewart H Mostofsky; Jason P Lerch; Peter T Tsai
Journal:  Nat Neurosci       Date:  2017-10-30       Impact factor: 24.884

5.  Non-motor associative learning in patients with isolated degenerative cerebellar disease.

Authors:  J Drepper; D Timmann; F P Kolb; H C Diener
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

6.  Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia.

Authors:  S J Kish; M el-Awar; L Schut; L Leach; M Oscar-Berman; M Freedman
Journal:  Ann Neurol       Date:  1988-08       Impact factor: 10.422

7.  Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.

Authors:  Anabela Silva-Fernandes; Sara Duarte-Silva; Andreia Neves-Carvalho; Marina Amorim; Carina Soares-Cunha; Pedro Oliveira; Kenneth Thirstrup; Andreia Teixeira-Castro; Patrícia Maciel
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

8.  Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator.

Authors:  Harry J Han; Carolyn C Allen; Christie M Buchovecky; Michael J Yetman; Heather A Born; Miguel A Marin; Shaefali P Rodgers; Bryan J Song; Hui-Chen Lu; Monica J Justice; Frank J Probst; Joanna L Jankowsky
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

9.  Location of lesion determines motor vs. cognitive consequences in patients with cerebellar stroke.

Authors:  Catherine J Stoodley; Jason P MacMore; Nikos Makris; Janet C Sherman; Jeremy D Schmahmann
Journal:  Neuroimage Clin       Date:  2016-10-15       Impact factor: 4.881

10.  Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.

Authors:  Tetsuo Ashizawa; Karla P Figueroa; Susan L Perlman; Christopher M Gomez; George R Wilmot; Jeremy D Schmahmann; Sarah H Ying; Theresa A Zesiewicz; Henry L Paulson; Vikram G Shakkottai; Khalaf O Bushara; Sheng-Han Kuo; Michael D Geschwind; Guangbin Xia; Pietro Mazzoni; Jeffrey P Krischer; David Cuthbertson; Amy Roberts Holbert; John H Ferguson; Stefan M Pulst; S H Subramony
Journal:  Orphanet J Rare Dis       Date:  2013-11-13       Impact factor: 4.123

View more
  4 in total

Review 1.  The extra-cerebellar effects of spinocerebellar ataxia type 1 (SCA1): looking beyond the cerebellum.

Authors:  Victor Olmos; Neha Gogia; Kimberly Luttik; Fatema Haidery; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2022-07-08       Impact factor: 9.207

2.  Cerebellum and Emotion Memory.

Authors:  Melanie Mark; Johanna Pakusch; Thomas M Ernst; Dagmar Timmann
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

4.  Mood alterations in mouse models of Spinocerebellar Ataxia type 1.

Authors:  Melissa Asher; Juao-Guilherme Rosa; Marija Cvetanovic
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.